<DOC>
	<DOCNO>NCT00903240</DOCNO>
	<brief_summary>The purpose study detect recurrent bladder cancer use combination protein DNA biomarkers urine</brief_summary>
	<brief_title>Observational Study Subjects Having Routine Recurrence Screening Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Intact bladder Scheduled cystoscopy transitional cell bladder cancer recurrence screen Urine donate prior cystoscopy , Bladder biopsy , chemotherapy , intravesical therapy , radiation TUR Must willing sign IRB approve informed consent History current diagnosis cancer except transitional cell bladder cancer basal cell cancer Known diagnosis autoimmune disease HIV , HCV HBV History current TB active infection Subject gross hematuria Receiving chemotherapy , intravesical therapy radiation within 30 day enrollment Any surgery except urologic within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>